These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26796140)

  • 1. Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain.
    Droppa-Almeida D; Vivas WL; Silva KK; Rezende AF; Simionatto S; Meyer R; Lima-Verde IB; Delagostin O; Borsuk S; Padilha FF
    Vaccine; 2016 Feb; 34(8):1091-6. PubMed ID: 26796140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corynebacterium pseudotuberculosis cp09 mutant and cp40 recombinant protein partially protect mice against caseous lymphadenitis.
    Silva JW; Droppa-Almeida D; Borsuk S; Azevedo V; Portela RW; Miyoshi A; Rocha FS; Dorella FA; Vivas WL; Padilha FF; Hernández-Macedo ML; Lima-Verde IB
    BMC Vet Res; 2014 Dec; 10():965. PubMed ID: 25527190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Corynebacterium pseudotuberculosis recombinant proteins rCP09720 or rCP01850 with rPLD as immunogens in caseous lymphadenitis immunoprophylaxis.
    Silva MTO; Bezerra FSB; de Pinho RB; Begnini KR; Seixas FK; Collares T; Portela RD; Azevedo V; Dellagostin O; Borsuk S
    Vaccine; 2018 Jan; 36(1):74-83. PubMed ID: 29174312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant esterase from Corynebacterium pseudotuberculosis in DNA and subunit recombinant vaccines partially protects mice against challenge.
    Brum AA; Rezende AFS; Brilhante FS; Collares T; Begnine K; Seixas FK; Collares TV; Dellagostin OA; Azevedo V; Santos A; Portela RW; Borsuk S
    J Med Microbiol; 2017 May; 66(5):635-642. PubMed ID: 28516859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral and cellular immune responses in mice against secreted and somatic antigens from a Corynebacterium pseudotuberculosis attenuated strain: Immune response against a C. pseudotuberculosis strain.
    Vale VL; Silva Mda C; de Souza AP; Trindade SC; de Moura-Costa LF; Dos Santos-Lima EK; Nascimento IL; Cardoso HS; Marques Ede J; Paule BJ; Nascimento RJ
    BMC Vet Res; 2016 Sep; 12(1):195. PubMed ID: 27608632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis.
    Fontaine MC; Baird G; Connor KM; Rudge K; Sales J; Donachie W
    Vaccine; 2006 Aug; 24(33-34):5986-96. PubMed ID: 16806606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral and cellular immune responses of a murine model against Corynebacterium pseudotuberculosis antigens.
    El-Enbaawy MI; Saad MM; Selim SA
    Egypt J Immunol; 2005; 12(2):13-9. PubMed ID: 17977206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide vaccines designed with the aid of immunoinformatic against Caseous Lymphadenitis promotes humoral and cellular response induction in mice.
    Droppa-Almeida D; da Silva GA; Gaspar LMDAC; Pereyra BBS; Nascimento RJM; Borsuk S; Franceschi E; Padilha FF
    PLoS One; 2021; 16(11):e0256864. PubMed ID: 34843474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NanH and PknG putative virulence factors as a recombinant subunit immunogen against Corynebacterium pseudotuberculosis infection in mice.
    Thais de Oliveira Silva M; Barros de Pinho R; da Rocha Fonseca B; Silvestre Brilhante Bezerra F; Severo Sabedra Sousa F; Kommling Seixas F; Collares T; José Meyer Nascimento R; Wagner Portela R; Ariston Carvalho Azevedo V; Borsuk S
    Vaccine; 2020 Dec; 38(51):8099-8106. PubMed ID: 33190945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the humoral and cellular immune response to different antigens of Corynebacterium pseudotuberculosis in Canindé goats and their potential protection against caseous lymphadenitis.
    Moura-Costa LF; Bahia RC; Carminati R; Vale VL; Paule BJ; Portela RW; Freire SM; Nascimento I; Schaer R; Barreto LM; Meyer R
    Vet Immunol Immunopathol; 2008 Nov; 126(1-2):131-41. PubMed ID: 18752855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An iron-acquisition-deficient mutant of Corynebacterium pseudotuberculosis efficiently protects mice against challenge.
    Ribeiro D; Rocha Fde S; Leite KM; Soares Sde C; Silva A; Portela RW; Meyer R; Miyoshi A; Oliveira SC; Azevedo V; Dorella FA
    Vet Res; 2014 Mar; 45(1):28. PubMed ID: 24597857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D.
    Hodgson AL; Carter K; Tachedjian M; Krywult J; Corner LA; McColl M; Cameron A
    Vaccine; 1999 Feb; 17(7-8):802-8. PubMed ID: 10067685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprophylactic properties of the Corynebacterium pseudotuberculosis-derived MBP:PLD:CP40 fusion protein.
    Barral TD; Kalil MA; Mariutti RB; Arni RK; Gismene C; Sousa FS; Collares T; Seixas FK; Borsuk S; Estrela-Lima A; Azevedo V; Meyer R; Portela RW
    Appl Microbiol Biotechnol; 2022 Dec; 106(24):8035-8051. PubMed ID: 36374330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection in alpacas against Corynebacterium pseudotuberculosis using different bacterial components.
    Braga WU
    Vet Microbiol; 2007 Jan; 119(2-4):297-303. PubMed ID: 16982160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of sheep against caseous lymphadenitis by use of a single oral dose of live recombinant Corynebacterium pseudotuberculosis.
    Hodgson AL; Tachedjian M; Corner LA; Radford AJ
    Infect Immun; 1994 Dec; 62(12):5275-80. PubMed ID: 7960105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired immunity after primary caseous lymphadenitis in sheep.
    Pépin M; Pardon P; Marly J; Lantier F; Arrigo JL
    Am J Vet Res; 1993 Jun; 54(6):873-7. PubMed ID: 8323055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines for caseous lymphadenitis: up-to-date and forward-looking strategies.
    de Pinho RB; de Oliveira Silva MT; Bezerra FSB; Borsuk S
    Appl Microbiol Biotechnol; 2021 Mar; 105(6):2287-2296. PubMed ID: 33651132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant modulation of the immune response of mice against the LcrE protein of Chlamydophila pneumoniae.
    Faludi I; Burian K; Csanadi A; Miczak A; Lu X; Kakkar VV; Gonczol E; Endresz V
    Int J Med Microbiol; 2009 Nov; 299(7):520-8. PubMed ID: 19451031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunisation against ovine caseous lymphadenitis: correlation between Corynebacterium pseudotuberculosis toxoid content and protective efficacy in combined clostridial-corynebacterial vaccines.
    Eggleton DG; Haynes JA; Middleton HD; Cox JC
    Aust Vet J; 1991 Oct; 68(10):322-5. PubMed ID: 1755783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine potential of attenuated mutants of Corynebacterium pseudotuberculosis in sheep.
    Simmons CP; Dunstan SJ; Tachedjian M; Krywult J; Hodgson AL; Strugnell RA
    Infect Immun; 1998 Feb; 66(2):474-9. PubMed ID: 9453598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.